New Genetic Evidence Reveals a Neuronal Role in Multiple Sclerosis Susceptibility
Multiple sclerosis is traditionally understood as an immune-mediated disorder in which autoreactive lymphocytes, microglia, and inflammatory demyelination damage the central nervous system. The article “GWAS highlights the neuronal contribution to multiple sclerosis susceptibility” expands this model by arguing that MS susceptibility is not solely explained by peripheral immune dysregulation. Instead, the study proposes that neuronal and glial cell biology may participate directly in the earliest stages of disease risk, particularly through genetic variants that influence gene expression in specific brain cell populations.
Expansion of MS Susceptibility Mapping
The authors performed a large multi-ancestry genome-wide association study involving 20,831 MS cases and 729,220 controls, while focusing on susceptibility variants outside the extended Major Histocompatibility Complex region. This analysis identified 236 independent non-MHC MS susceptibility variants, including four novel loci, thereby strengthening the genetic map of MS risk beyond the historically dominant immune-related loci. The study also incorporated UK Biobank, eMERGE, and All of Us datasets, making the analysis substantially broader than earlier European-centered studies.
The Importance and Limits of Multi-Ancestry Analysis
A significant feature of the study is its attempt to evaluate MS genetics across European, African-American, and Admixed American populations. The authors detected one genome-wide significant locus in African-American participants and two in Admixed American participants, but they appropriately caution that these findings require replication because non-European sample sizes remain modest. This point is scientifically important: genomic medicine cannot become clinically equitable if risk loci and prediction tools are optimized only in European ancestry cohorts.
Polygenic Scores and Clinical Stratification
The study developed a genome-wide polygenic score for MS and tested it in an independent eMERGE cohort. In European ancestry participants, each standard deviation increase in the score was associated with a higher risk of MS, and individuals in the top 1% of the score distribution had more than a sevenfold increased risk compared with the remaining 99%. The score also showed informative, though weaker, performance in African-American and Admixed American groups, indicating both translational promise and the need for ancestry-aware optimization before clinical deployment.
Shared Autoimmune Architecture and Disease Specificity
The authors also examined whether MS risk variants overlap with other autoimmune, neurodegenerative, psychiatric, and metabolic traits. They found that many MS susceptibility variants share genetic architecture with autoimmune diseases such as inflammatory bowel disease, celiac disease, psoriasis, systemic lupus erythematosus, rheumatoid arthritis, and type 1 diabetes. However, the relationship is not simply a universal “autoimmunity risk” model: some alleles show opposite effects across diseases, and a subset of MS variants appears more disease-specific, potentially helping explain why autoimmunity targets the brain and spinal cord in MS rather than other tissues.
Inhibitory Neurons Emerge as an Unexpected Cell Type
The most conceptually important finding is the cell-type-specific functional analysis. By integrating MS GWAS results with expression quantitative trait loci from blood and dorsolateral prefrontal cortex cell types, the authors confirmed strong involvement of immune cells, particularly naïve CD4+ T cells. Unexpectedly, however, inhibitory neurons showed the largest number of colocalized MS susceptibility effects among central nervous system cell types, exceeding microglia in this analysis. The loci involving IL7 and STAT3 were especially notable because their susceptibility and expression effects appeared specific to inhibitory neurons, suggesting a possible molecular bridge between immune activation and CNS vulnerability.
Implications for Future MS Research
This article reframes MS susceptibility as a neuroimmune phenomenon in which peripheral immune dysregulation remains central but is not biologically sufficient to explain disease onset. The data suggest that neurons, astrocytes, oligodendrocytes, and microglia may shape how inflammatory risk becomes anatomically focused within the CNS. The immediate implication is that future MS prevention and therapeutic research should not focus exclusively on systemic immune suppression; it should also investigate CNS-resident pathways, neuronal resilience, glial responses, and cell-resolved regulatory mechanisms that determine why genetically susceptible individuals develop inflammatory demyelination and later neurodegeneration.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
De Jager, P., Zeng, L., Khan, A., Lama, T., Chitnis, T., Weiner, H., ... & Kiryluk, K. (2025). GWAS highlights the neuronal contribution to multiple sclerosis susceptibility. Research Square, rs-3.
